Clinical Epidemiology of Gestational Trophoblastic Disease

被引:0
|
作者
Strohl, Anna E. [1 ]
Lurain, John R. [1 ,2 ]
机构
[1] Northwestern Univ Feinberg, John I Brewer Trophoblast Dis Ctr, Dept Obstet & Gynecol, Chicago, IL USA
[2] Northwestern Univ Feinberg, Prentice Womens Hosp, Sch Med, 250 East Super St,Suite 05-2168, Chicago, IL 60611 USA
来源
CURRENT OBSTETRICS AND GYNECOLOGY REPORTS | 2014年 / 3卷 / 01期
关键词
Choriocarcinoma; Epidemiology; Gestational trophoblastic disease; GTD; Gestational trophoblastic neoplasia; Hydatidiformmole; Molar pregnancy; Clinical epidemiology;
D O I
10.1007/s13669-013-0070-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The epidemiology of gestational trophoblastic disease (GTD) is not well defined. The rarity of the disease and challenges in data collection limit interpretation of incidence data. Incidence of GTD appears to be influenced by geographic region, with the highest rates occurring in Southeast Asia and Japan. Risk factors for molar pregnancy include extremes of maternal age, reproductive history, and dietary deficiencies. Risk factors for choriocarcinoma include age, ethnicity, history of complete molar pregnancy, and ABO blood group status. With improvements in socioeconomic conditions and diet as well as diagnosis and management of GTD, the incidence of trophoblastic disease is declining worldwide. Future studies should focus on mechanisms by which risk factors influence development and progression of GTD.
引用
收藏
页码:40 / 43
页数:4
相关论文
共 50 条
  • [11] Gestational trophoblastic disease
    Allias, Fabienne
    Bolze, Pierre-Adrien
    Gaillot-Durand, Lucie
    Devouassoux-Shisheboran, Mojgan
    ANNALES DE PATHOLOGIE, 2014, 34 (06) : 434 - 447
  • [12] SEOM clinical guidelines in gestational trophoblastic disease (2017)
    Santaballa, A.
    Garcia, Y.
    Herrero, A.
    Lainez, N.
    Fuentes, J.
    De Juan, A.
    Rodriguez Freixinos, V.
    Aparicio, J.
    Casado, A.
    Garcia-Martinez, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 38 - 46
  • [13] GESTATIONAL TROPHOBLASTIC DISEASE
    BERKOWITZ, RS
    GOLDSTEIN, DP
    CANCER, 1995, 76 (10) : 2079 - 2085
  • [14] Gestational Trophoblastic Disease
    Shanbhogue, Alampady K. P.
    Lalwani, Neeraj
    Menias, Christine O.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2013, 51 (06) : 1023 - +
  • [15] Expression of maspin in gestational trophoblastic disease
    Li, HWR
    Leung, SW
    Cheung, ANY
    Yu, MMY
    Chan, LKY
    Wong, YF
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 76 - 81
  • [16] Epigenetic Dysregulation of Trophoblastic Gene Expression in Gestational Trophoblastic Disease
    Szabolcsi, Zoltan
    Demeter, Amanda
    Kiraly, Peter
    Balogh, Andrea
    Wilson, Melissa L.
    King, Jennifer R.
    Hetey, Szabolcs
    Gelencser, Zsolt
    Matsuo, Koji
    Hargitai, Beata
    Mhawech-Fauceglia, Paulette
    Hupuczi, Petronella
    Szilagyi, Andras
    Papp, Zoltan
    Roman, Lynda D.
    Cortessis, Victoria K.
    Than, Nandor Gabor
    BIOMEDICINES, 2021, 9 (12)
  • [17] Clinical Epidemiology and Management of Gestational Trophoblastic Neoplasia in Hungary in the Past 34 Years
    Fueloep, Vilmos
    Szigetvari, Ivan
    Szepesi, Janos
    Vegh, Gyorgy
    Singh, Margit
    Berkowitz, Ross S.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (7-8) : 310 - 318
  • [18] Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia
    Lurain, John R.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (01) : 11 - 18
  • [19] Treating gestational trophoblastic disease
    Rodriguez, Noah
    Goldstein, Donald P.
    Berkowitz, Ross S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (18) : 3027 - 3039
  • [20] Gestational trophoblastic disease.
    Schorge J.O.
    Goldstein D.P.
    Bernstein M.R.
    Berkowitz R.S.
    Current Treatment Options in Oncology, 2000, 1 (2) : 169 - 175